US Stock MarketDetailed Quotes
CORT Corcept Therapeutics
Watchlist
26.540
-0.190-0.71% Close 12/08 16:00 ET
26.980High26.460Low369.62KVolume
26.740Open26.730Pre Close9.84MTurnover0.44%Turnover Ratio33.18P/E (TTM)2.74BMarket Cap34.27552wk High30.51P/E (Static)103.08MShares17.86052wk Low5.93P/B2.25BFloat Cap34.275Historical High--Dividend TTM84.65MShs Float0.680Historical Low--Div YieldTTM1.95%Amplitude26.631Avg Price1Lot Size
About Corcept Therapeutics Company
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
Company Profile
SymbolCORT
Company NameCorcept Therapeutics
Listing Date04/14/2004
Issue Price12.00
Founded1998
CEODr. Joseph K. Belanoff, M.D.
MarketNASDAQ
Employees299
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address149 Commonwealth Drive
CityMenlo Park
ProvinceCalifornia
CountryUnited States of America
Zip Code94025
Phone1-650-327-3270
Websitehttp://www.corcept.com
Company Executives
- Name
- Position
- Salary
- Dr. Joseph K. Belanoff, M.D.
- Director, President and Chief Executive Officer
- 7.35M
- G. Charles Robb
- Chief Business Officer and Secretary
- 3.20M
- Atabak Mokari
- Chief Financial Officer and Treasurer
- 1.89M
- Joseph Douglas Lyon
- Chief Accounting Officer
- --
- Dr. Hazel Hunt, PhD
- Chief Scientific Officer
- 3.11M
- Dr. William Guyer, Pharm.D.
- Chief Development Officer
- --
- James N. Wilson
- Chairman of the Board
- 678.99K
- Sean Maduck
- President, Corcept Endocrinology
- 3.71M
- David L. Mahoney
- Independent Director
- 328.27K
- Daniel N. Swisher,Jr
- Independent Director
- 305.77K
- George Leonard Baker, Jr
- Independent Director
- 311.77K
- Gregg H. Alton, J.D.
- Independent Director
- 330.77K
- Kimberly Park
- Independent Director
- 307.77K
- Dr. Gillian M. Cannon, PhD
- Independent Director
- 314.27K
- Joshua M. Murray
- Independent Director
- 308.27K
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--